A bone marrow transplant is a treatment that replaces the damaged or diseased bone marrow with healthy blood-forming stem cells. A stem cell transplant is another name for a bone marrow transplant. For patients with hematologic malignancies, hematopoietic cell transplantation (HCT) is a life-prolonging or potentially curative therapy option. These therapeutic techniques were initially limited to younger patients due to the significant transplant-related morbidity, but they are increasingly being employed in older adults. The incidence of most hematologic malignancies rises with age, and as the population ages, so does the number of prospective older HCT candidates. Allogeneic haemopoietic stem cell transplantation (HSCT) is used to treat a limited number of individuals with a variety of malignant and non-malignant blood illnesses, as well as other immune system problems.
Title : Phlebotomy therapy in Sickle cell disease of double heterozygosity HbSC and rare congenital erythrocytosis in hemoglobin variants
Epifania Rita Testa, S Maria degli Angeli Hospital, Italy
Title : The utility of SYNTAX score predictability by electrocardiogram parameters in patients with unstable angina
Hamed Bazrafshan, Shiraz University of Medical Sciences, Iran (Islamic Republic of)
Title : Safety of not withholding Clopidogrel Therapy during the immediate several days pre and post Trans-Urethral Resection of Prostate (TURP) A retrospective cohort study
Ahmed Kamel Abdulhamid, University of Kerbala, Iraq
Title : The contested market of plasma
Jean Mercier Ythier, University of Paris-Panthéon-Assas, France
Title : Muscle Strength and Quality of life in children with Sickle Cell Anemia
Noha Hassan Mahboub, Cairo University, Egypt